After a Miserable Year, We Substitute Five New Funds
The past year has been nothing short of catastrophic for funds of nearly all stripes.
The past year has been nothing short of catastrophic for funds of nearly all stripes. Almost every market crashed. Over the past year through March 6, Standard & Poor's 500-stock index surrendered 46%. The Russell 2000 index of small companies plummeted by the same amount, and the beleaguered MSCI EAFE index, which tracks foreign stocks, lost 53%.
The 15 domestic stock funds in the Kiplinger 25 performed even worse than the index, losing 51%, on average. Our foreign funds plunged by 55%, on average. Our five bond funds lost an average of 6%.
All three of our recommended portfolios took a thrashing. The long-term (and most aggressive) portfolio shed 54%, hurt by a substantial weighting in foreign stocks and disastrous domestic performers, such as CGM Focus. The short-term package was the most conservative, but it wasn't conservative enough. Despite a 40% weighting in bonds, it lost 34%. The medium-term portfolio surrendered 41%.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
We have made five switches in this year's Kiplinger 25. We bid farewell to Bill Miller's Legg Mason Opportunity, which has performed dreadfully (and charges high fees), even compared with the sorry results of the index. We replaced Miller's fund with FPA Crescent (FPACX), managed by Steve Romick, a shrewd value investor who, like Miller, is able to sell short stocks that he believes are overpriced. At last report, Crescent had about one-fourth of its assets in bonds. Romick also had 5% of the fund's assets in stocks sold short.
We dropped Bridgeway Aggressive Investors II because of a lack of transparency in its purely quantitative investment methodology. We let loose Marsico 21st Century but retained Marsico Global; the funds have some overlap in their holdings. We also let go Kinetics Paradigm, an idiosyncratic fund whose recent returns have not justified its stiff fees.
We dropped T. Rowe Price Growth Stock, a perfectly respectable fund, and replaced it with the recently reopened Fidelity Contrafund (FCNTX). Contra, a large-company growth fund, has an outstanding record under its long-tenured manager, Will Danoff.
In a similar vein, we're happy to add three other recently reopened funds (one of the few benefits of this brutal bear market is that many excellent funds that had closed their doors have resumed accepting money from new investors). Fidelity Low-Priced Stock (FLPSX), which holds an enormous portfolio of mostly small and midsize companies, has been expertly run since 1989 by the redoubtable Joel Tillinghast.
We also jumped at the chance to add two fine T. Rowe Price funds to our list. Both are managed by long-tenured, steady managers: Preston Athey runs Small-Cap Value (PRSVX), and Brian Berghuis pilots Mid-Cap Growth (RPMGX).
OUT
Legg Mason Opportunity
Bridgeway Aggressive Investors II
Marsico 21st Century
Kinetics Paradigm
T. Rowe Price Growth Stock
IN
FPA Crescent
Fidelity Contrafund
Fidelity Low-Priced Stock
T. Rowe Price Small-Cap Value
T. Rowe Price Mid-Cap Growth
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Andrew Tanzer is an editorial consultant and investment writer. After working as a journalist for 25 years at magazines that included Forbes and Kiplinger’s Personal Finance, he served as a senior research analyst and investment writer at a leading New York-based financial advisor. Andrew currently writes for several large hedge and mutual funds, private wealth advisors, and a major bank. He earned a BA in East Asian Studies from Wesleyan University, an MS in Journalism from the Columbia Graduate School of Journalism, and holds both CFA and CFP® designations.
-
Stock Market Today: Stocks End Higher in Whipsaw Session
The main indexes were volatile Thursday with Nvidia earnings in focus.
By Karee Venema Published
-
Trump Picks Dr. Oz as Head of Medicare and Medicaid
President-elect Donald Trump picked Dr. Mehmet Oz to lead the Centers for Medicare and Medicaid Services. Here's what to know about the former TV host.
By Kathryn Pomroy Published
-
Best Banks for High-Net-Worth Clients 2024
wealth management These banks welcome customers who keep high balances in deposit and investment accounts, showering them with fee breaks and access to financial-planning services.
By Lisa Gerstner Last updated
-
Stock Market Holidays in 2024: NYSE, NASDAQ and Wall Street Holidays
Markets When are the stock market holidays? Here, we look at which days the NYSE, Nasdaq and bond markets are off in 2024.
By Kyle Woodley Last updated
-
Stock Market Trading Hours: What Time Is the Stock Market Open Today?
Markets When does the market open? While the stock market does have regular hours, trading doesn't necessarily stop when the major exchanges close.
By Michael DeSenne Last updated
-
Bogleheads Stay the Course
Bears and market volatility don’t scare these die-hard Vanguard investors.
By Kim Clark Published
-
The Current I-Bond Rate Until May Is Mildly Attractive. Here's Why.
Investing for Income The current I-bond rate is active until November 2024 and presents an attractive value, if not as attractive as in the recent past.
By David Muhlbaum Last updated
-
What Are I-Bonds? Inflation Made Them Popular. What Now?
savings bonds Inflation has made Series I savings bonds, known as I-bonds, enormously popular with risk-averse investors. So how do they work?
By Lisa Gerstner Last updated
-
This New Sustainable ETF’s Pitch? Give Back Profits.
investing Newday’s ETF partners with UNICEF and other groups.
By Ellen Kennedy Published
-
As the Market Falls, New Retirees Need a Plan
retirement If you’re in the early stages of your retirement, you’re likely in a rough spot watching your portfolio shrink. We have some strategies to make the best of things.
By David Rodeck Published